Antidiabetogenic effects of hydroxychloroquine on insulin sensitivity and beta cell function: a randomised trial
Antidiabetogenic effects of hydroxychloroquine on insulin sensitivity and beta cell function: a randomised trial
M. Wasko,C. McClure,3 Authors,F. Toledo
2015 · DOI: 10.1007/s00125-015-3689-2
Diabetologia · 84 Citations
TLDR
The findings suggest that HCQ is a drug with considerable metabolic effects that warrant further exploration in disorders of glucose metabolism, and improves both beta cell function and insulin sensitivity in non-diabetic individuals.